Prolonged treatment with transdermal fentanyl in neuropathic pain

Journal of Pain and Symptom Management

Volumn 16, Issue 4, 1998, Pages 220-229

  Dellemijn, Paul L I ^a,b   Van Duijn, Hans ^a   Vanneste, Jan A L ^a  

^a ST JOSEPH HOSPITAL   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Clinical trial; Cutaneous; Drug treatment; Fentanyl; Neuropathic pain; Opioids; Pain; Quality of life; Side effects; Transdermal delivery

Indexed keywords

FENTANYL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DRUG TOLERANCE; DYSPNEA; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; NAUSEA; NEUROPATHY; PAIN; PROSPECTIVE STUDY; QUALITY OF LIFE; SOMNOLENCE; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEURALGIA; TIME FACTORS;

EID: 0032190657     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00070-0     Document Type: Article

References (30)

1. Willner C., Low P.A. Pharmacologic approaches to neuropathic pain. Dyck P.J. Peripheral neuropathy. 1993;1709-1720 Saunders, Philadelphia.
2. Portenoy R.K. Neuropathic pain. Portenoy R.K., Kanner R.M. Pain management. theory and practice:1996;83-125 FA Davis, Philadelphia.
3. Zenz M., Strumpf M., Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage. 7:1992;69-77.
4. Winkelmüller M., Winkelmüller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 85:1996;458-467.
5. Urban B.J., France R.D., Steinberger E.K., Scott D.L., Maltbie A.A. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain. 24:1986;191-196.
6. Portenoy R.K., Foley K.M. Chronic use of opioid analgesics in non-malignant pain. report of 38 cases Pain. 25:1986;171-186.
7. Schulzeck S., Gleim M., Maier C. Morphintabletten bei chronischen nicht-tumorbedingten Schmerzen. Welche Faktoren beeinflussen Erfolg oder Miserfolg einer Langzeittherapie? Anaesthesist. 42:1993;545-556.
8. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of non-malignant origin. J Pain Symptom Manage. 8:1993;279-288.
9. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. Kitahata L.M., Collins D. Narcotic analgesics in anesthesiology. 1982;199-208 Williams and Wilkins, Baltimore.
10. Brena S.F., Sanders S.H. Opioids in nonmalignant pain. questions in search of answers Clin J Pain. 7:1991;342-345.
11. Moulin D.E., Iezzi A., Amireh R., Sharpe W.K.J., Boyd D., Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 347:1996;143-147.
12. Portenoy R.K. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 5:1990;46-62.
13. Fishbain D.A., Rosomoff H.L., Rosomoff R.S. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain. 8:1992;77-85.
14. Arnér S., Meyerson B.A. Opioids in neuropathic pain. Pain Digest. 3:1993;15-22.
15. Gourlay G.K. Long-term use of opioids in chronic pain patients with nonterminal disease. Pain Rev. 1:1994;62-76.
16. Jamison R.N., Anderson K.O., Peeters-Asdourian C., Ferrante F.M. Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth. 19:1994;225-230.
17. Dellemijn P.L.I., Vanneste J.A.L. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 349:1997;753-758.
18. Bennett G.J. Neuropathic pain. Melzack R., Wall P.D. Textbook of pain. 1994;201-224 Churchill Livingstone, Edinburgh.
19. Dellemijn P.L.I., Fields H.L., Allen R.R., McKay W.R., Rowbotham M.C. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain. 117:1994;1475-1487.
20. Dellemijn PLI, Deuning C, Laman DM and van Duijn H. Sensory disturbances in neuropathic pain. In: Neuropathic pain. Thesis. University of Amsterdam. Maastricht: Shaker Publishing, 1997:45-62.
21. Kupers R.C., Konings H., Adriaensen H., Gybels J.M. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain. 47:1991;5-12.
22. Zung W.W.K. A self-rating depression scale. Arch Gen Psychiatry. 12:1965;63-70.
23. Padilla G.V., Presant C., Grant M.M., Metter G., Lipsett J., Heide F. Quality of life index for patients with cancer. Res Nurs Health. 6:1983;117-126.
24. Bouckoms A.J., Masand P., Murray G.B., Cassem E.H., Stern T.A., Tesar G.E. Chronic non-malignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychiatry. 4:1992;185-192.
25. Finlayson R.D., Maruta T., Morse B.R., Martin B.A. Substance dependence and chronic pain. experience with treatment and follow-up results [Abstract] Pain. 26:1986;175-180.
26. France R.D., Urban B.J., Keefe F.J. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med. 19:1984;1379-1382.
27. Ahmedzai S, Brooks D, on behalf of the TTS-fentanyl Comparative Trial Group. Transdermal fentanyl versus sustained-release morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 1997;13:254-261.
28. Porter J., Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 302:1980;123.
29. Medina J.I., Diamond S. Drug dependency in patients with chronic headache. Headache. 17:1977;12-14.
30. Perry S., Heidrich G. Management of pain during debridement. survey of US burn units Pain. 13:1982;267-280.